Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Susanna Bordignon"'
Autor:
Antonella Casiraghi, Chiara Grazia Gennari, Umberto Maria Musazzi, Marco Aldo Ortenzi, Susanna Bordignon, Paola Minghetti
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 822 (2020)
The paper entitled “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211” discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis
Externí odkaz:
https://doaj.org/article/456437e83687498eb19a94f0c2d27048
Autor:
Antonella Casiraghi, Chiara Grazia Gennari, Umberto Maria Musazzi, Marco Aldo Ortenzi, Susanna Bordignon, Paola Minghetti
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 211 (2020)
Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease for which off-label topical corticosteroids (e.g., budesonide) are widely used in clinic. In general, thickening excipients are mixed with industrial p
Externí odkaz:
https://doaj.org/article/ba0a4365da7242a2a77923d93de6586f
Autor:
Chiara G.M. Gennari, Umberto M. Musazzi, Susanna Bordignon, Antonella Casiraghi, Paola Minghetti, Marco Aldo Ortenzi
Publikováno v:
Pharmaceutics, Vol 12, Iss 822, p 822 (2020)
Pharmaceutics
Pharmaceutics
The paper entitled “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211” discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5e0c8c5b1751115b6f725b45d0244e
https://www.mdpi.com/1999-4923/12/9/822
https://www.mdpi.com/1999-4923/12/9/822
Autor:
Stefano Loiacono, Antonella Casiraghi, R Puzziferri, P Minghetti, Francesco Cilurzo, Susanna Bordignon
Publikováno v:
Section 3: Production and Compounding.
Background Flecainide acetate (FlecAc) is an antiarrhythmic drug, effective in children and fetal tachyarrhythmias. FlecAc is commercially available as 50 mg–150 mg oral tablets or intravenous injectable solutions, approved only for use in adults.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::200f87a50513bf4a640bd8c9233f8f8d
https://doi.org/10.1136/ejhpharm-2019-eahpconf.126
https://doi.org/10.1136/ejhpharm-2019-eahpconf.126
Autor:
Susanna Bordignon, Francesco Cattel, Alessandra Bianco, Diego Antonio Barila, Giulia Valinotti
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:124-124
INTRODUCTION:Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The goal of HCV therapy is to eradicate the infection, which results in eliminating detectable circulating HCV after cessation of treatment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bba60f453ba377ecb4e2f87b7da03d2
https://doi.org/10.1017/s0266462317002719
https://doi.org/10.1017/s0266462317002719
Autor:
Perrone, Francesco1 (AUTHOR) f.perrone@istitutotumori.na.it, Piccirillo, Maria Carmela1 (AUTHOR), Ascierto, Paolo Antonio2 (AUTHOR), Salvarani, Carlo3 (AUTHOR), Parrella, Roberto4 (AUTHOR), Marata, Anna Maria5 (AUTHOR), Popoli, Patrizia6 (AUTHOR), Ferraris, Laurenzia7 (AUTHOR), Marrocco-Trischitta, Massimiliano M.7 (AUTHOR), Ripamonti, Diego8 (AUTHOR), Binda, Francesca8 (AUTHOR), Bonfanti, Paolo9 (AUTHOR), Squillace, Nicola9 (AUTHOR), Castelli, Francesco10 (AUTHOR), Muiesan, Maria Lorenza10 (AUTHOR), Lichtner, Miriam11 (AUTHOR), Calzetti, Carlo12 (AUTHOR), Salerno, Nicola Duccio13 (AUTHOR), Atripaldi, Luigi4 (AUTHOR), Cascella, Marco14 (AUTHOR)
Publikováno v:
Journal of Translational Medicine. 11/22/2021, Vol. 19 Issue 1, p1-11. 11p.
Autor:
Casiraghi, Antonella1 (AUTHOR) antonella.casiraghi@unimi.it, Gennari, Chiara Grazia1 (AUTHOR) umberto.musazzi@unimi.it, Musazzi, Umberto Maria1 (AUTHOR) paola.minghetti@unimi.it, Ortenzi, Marco Aldo2,3 (AUTHOR) marco.ortenzi@unimi.it, Bordignon, Susanna4 (AUTHOR) susanna.bordignon@gmail.com, Minghetti, Paola1 (AUTHOR)
Publikováno v:
Pharmaceutics. Sep2020, Vol. 12 Issue 9, p822. 1p.
Autor:
Casiraghi, Antonella1 (AUTHOR) antonella.casiraghi@unimi.it, Gennari, Chiara Grazia1 (AUTHOR) umberto.musazzi@unimi.it, Musazzi, Umberto Maria1 (AUTHOR) paola.minghetti@unimi.it, Ortenzi, Marco Aldo2,3 (AUTHOR) marco.ortenzi@unimi.it, Bordignon, Susanna4 (AUTHOR) susanna.bordignon@gmail.com, Minghetti, Paola1 (AUTHOR)
Publikováno v:
Pharmaceutics. Mar2020, Vol. 12 Issue 3, p211. 1p.
Autor:
Barila, Diego Antonio, Bianco, Alessandra, Bordignon, Susanna, Cattel, Francesco, Valinotti, Giulia
Publikováno v:
International Journal of Technology Assessment in Health Care; 1/2/2017, Vol. 33, p123-124, 2p
Publikováno v:
International Journal of Technology Assessment in Health Care; 1/2/2017, Vol. 33, p123-123, 1p